Max Kennedy, Ph.D. FIChemE, FENZ, FNZIC, is the Manager Contestable Investments, at the New Zealand Ministry of Business, Innovation and Employment (MBIE) which invests the majority of the NZ Government’s Research funds. Max is responsible for R&D with impacts in economic, environment and societal area across several funds including the Endeavour Fund, New Zealand’s largest contestable research fund. Most recently Max has lead the COVID Innovation Acceleration Fund which assisted with New Zealand’s response to COVID-19.
Prior to this Max was Research and Development Strategy Manager at Meat and Wool NZ Ltd (MWNZ). Formerly Max was the Chief Scientific Officer of IRL-BioPharm Ltd, a New Zealand-based fermentation contract manufacturer of active pharmaceutical ingredients for human clinical trials under cGMP conditions.
Max received his doctorate in Biochemical Engineering from the Massachusetts Institute of Technology, USA. Max was awarded the Supreme Technical Award in Chemical BioProcess and Food Category by Engineering New Zealand of which he is a Fellow, the New Zealand Science and Technology Medal by the New Zealand Governor General and is a Fellow of the Institution of Chemical Engineers (IChemE) & the New Zealand Institute of Chemistry (NZIC).
Max has served as Director on the Boards 6 technology companies and was on the Fermentation Advisory Board of the anti-malaria project of OneWorld Health (a not for profit pharmaceutical company based in San Francisco, USA).
Go to session page: